Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study: Toxicity of oestradiol for adjuvant endocrine therapy in locally confined prostate cancer
2013-005479-42Phase 2Active
- Sponsor
- Erasmus MC
- Start
- Feb 2014
- Countries
- 1
01
Overview
Phase 2, single-arm trial of estradiol in prostate cancer (PCa), sponsored by Erasmus MC. Primary endpoint: Incidence of cardiovascular events. Started Feb 2014; status: active.
02
Drugs
estradiol
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on 2013-005479-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-005479-42.